Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Sébastien Wieckowski"'
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Pharmaceutical manufacturing relies on rigorous methods of quality control of drugs and in particular of the physico-chemical and functional characterizations of monoclonal antibodies. To that end, robust bioassays are very often limited to reporter
Externí odkaz:
https://doaj.org/article/7623c79e9e1547e8bbc48c41fffd818d
Autor:
Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, Lilli Podola, Tobias Friedrich, Heinz Lubenau, Marco Springer, Sébastien Wieckowski, Klaus M. Breiner, Gerd Mikus, Markus W. Büchler, Anne-Valerie Keller, Ruhan Koc, Christoph Springfeld, Phillip Knebel, Mariana Bucur, Lars Grenacher, Walter E. Haefeli, Philipp Beckhove
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
VXM01 is a first-in-kind orally applied tumor vaccine based on live attenuated Salmonella typhi carrying an expression plasmid encoding VEGFR2, an antigen expressed on tumor vasculature and a stable and accessible target for anti-angiogenic intervent
Externí odkaz:
https://doaj.org/article/f1654b6e955543cab1a035533acfbe75
Autor:
Antoine Leimgruber, Mathias Ferber, Melita Irving, Hamid Hussain-Kahn, Sébastien Wieckowski, Laurent Derré, Nathalie Rufer, Vincent Zoete, Olivier Michielin
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e26301 (2011)
TCRep 3D is an automated systematic approach for TCR-peptide-MHC class I structure prediction, based on homology and ab initio modeling. It has been considerably generalized from former studies to be applicable to large repertoires of TCR. First, the
Externí odkaz:
https://doaj.org/article/faa0b69c526f44d98ab040d69269f945
Autor:
Pedro Romero, Daniel E. Speiser, Immanuel F. Luescher, Jean-Marie Tiercy, William W. Kwok, Nathalie Rufer, Sébastien Wieckowski, Lukas Baitsch, Laurent Derré, Danijel Dojcinovic, Gilles Bioley, Camilla Jandus
We have previously shown that vaccination of HLA-A2 metastatic melanoma patients with the analogue Melan-A26-35(A27L) peptide emulsified in a mineral oil induces ex vivo detectable specific CD8 T cells. These are further enhanced when a TLR9 agonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eab1d6aa13b5590d2ee7e4235f69ef4
https://doi.org/10.1158/0008-5472.c.6500465
https://doi.org/10.1158/0008-5472.c.6500465
Autor:
Pedro Romero, Daniel E. Speiser, Immanuel F. Luescher, Jean-Marie Tiercy, William W. Kwok, Nathalie Rufer, Sébastien Wieckowski, Lukas Baitsch, Laurent Derré, Danijel Dojcinovic, Gilles Bioley, Camilla Jandus
Supplementary Figure 3 from Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f0615d49f4b8b52c11dbc910737f84
https://doi.org/10.1158/0008-5472.22383230.v1
https://doi.org/10.1158/0008-5472.22383230.v1
Autor:
Pedro Romero, Daniel E. Speiser, Immanuel F. Luescher, Jean-Marie Tiercy, William W. Kwok, Nathalie Rufer, Sébastien Wieckowski, Lukas Baitsch, Laurent Derré, Danijel Dojcinovic, Gilles Bioley, Camilla Jandus
Supplementary Figure 2 from Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d472beba34cee39b5ae23d6bc70b625
https://doi.org/10.1158/0008-5472.22383233.v1
https://doi.org/10.1158/0008-5472.22383233.v1
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Pharmaceutical manufacturing relies on rigorous methods of quality control of drugs and in particular of the physico-chemical and functional characterizations of monoclonal antibodies. To that end, robust bioassays are very often limited to reporter
Autor:
Michal A. Stanczak, Pankaj Shah, Naohiro Yoshida, Benjamin Kasenda, Nicole Kirchhammer, Abhishek S. Kashyap, Sung-Moo Park, Rachid Zagani, Sébastien Wieckowski, Laura Fernandez-Rodriguez, Gianni Monaco, Alfred Zippelius, Yun Zhao, Marcel P. Trefny, Hans Christian Reinecker, Ashwani Sharma, Michel O. Steinmetz, Kea Martin, Heinz Läubli, Natacha Olieric
Publikováno v:
Cell reports
Cell Reports, Vol 28, Iss 13, Pp 3367-3380.e8 (2019)
Cell Reports, Vol 28, Iss 13, Pp 3367-3380.e8 (2019)
SUMMARY Dendritic cell (DC) activation is a critical step for anti-tumor T cell responses. Certain chemotherapeutics can influence DC function. Here we demonstrate that chemotherapy capable of microtubule destabilization has direct effects on DC func
Autor:
Christoph Springfeld, Heinz Lubenau, Lars Grenacher, Lilli Podola, Ruhan Koc, Nicolas Hohmann, Klaus M. Breiner, Markus W. Büchler, Friedrich H. Schmitz-Winnenthal, Gerd Mikus, Phillip Knebel, Mariana Bucur, Marco Springer, Philipp Beckhove, Anne-Valerie Keller, Walter E. Haefeli, Thomas Schmidt, Sébastien Wieckowski, Tobias Friedrich
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
VXM01 is a first-in-kind orally applied tumor vaccine based on live attenuated Salmonella typhi carrying an expression plasmid encoding VEGFR2, an antigen expressed on tumor vasculature and a stable and accessible target for anti-angiogenic intervent
Autor:
Philippe Guillaume, Nathalie Rufer, Petra Baumgaertner, Daniel E. Speiser, Tanja Lövgren, Sébastien Wieckowski, Estelle Devevre, Immanuel F. Luescher
Publikováno v:
Cancer immunology immunotherapy : CII
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2012, 61 (6), pp.817-826. ⟨10.1007/s00262-011-1140-1⟩
Cancer Immunology, Immunotherapy, vol. 61, no. 6, pp. 817-826
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2012, 61 (6), pp.817-826. ⟨10.1007/s00262-011-1140-1⟩
Cancer Immunology, Immunotherapy, vol. 61, no. 6, pp. 817-826
International audience; In mice, vaccination with high peptide doses generates higher frequencies of specific CD8+ T cells, but with lower avidity compared to vaccination with lower peptide doses. To investigate the impact of peptide dose on CD8+ T c